HPA-1 diagnosis of platelet conflict in pregnant women

• The material for testing is blood.
• The patient does not need to fast. It is recommended to drink a glass of water approximately 30 minutes before the examination.

HPA-1a phenotype testing can be performed regardless of whether the patient is pregnant or not. In justified cases, it is advisable to test the antigen before a planned pregnancy, or, for example, on the child's father if the patient is HPA-1a negative.
A referral from a doctor is not required for the test.
Patients should bring their ID and a completed informed consent form (available for download at www.luxmedlublin.pl; it can also be completed at the clinic). It is recommended that the patient bring their pregnancy record/booklet with them.

Platelet incompatibility is one of the maternal-fetal serological conflicts. It is analogous to the commonly known RhD incompatibility, in which an RhD-negative woman produces antibodies to the fetal RhD antigen, but affects platelets, not red blood cells.
Platelet incompatibility is caused by the mother's production of antibodies against antigens on the fetus's or newborn's platelets. Antibody production occurs when the child of a woman who lacks the HPA-1a platelet antigen (HPA-1a negative) inherits this antigen from the father. Fetal disease appears asymptomatic in the mother and can occur as early as the first pregnancy.
Platelet incompatibility carries a risk of fetal thrombocytopenia (ITP) or thrombocytopenia in the newborn (AIMPN). It is rare (2% of the population) but is associated with serious complications. It can lead to intracranial hemorrhage, which can even cause the child's death; it can also leave traces such as epilepsy or paralysis.
By undergoing testing, a woman receives information that she is HPA1a positive (98% of women) and is not at risk for HPA1a antigen incompatibility, or that she is HPA1a negative (2% of women) and should undergo diagnostic testing during pregnancy and be under the care of gynecologists specializing in the treatment of platelet incompatibility.
Testing is recommended for all pregnant women, especially those who experienced complications in their first pregnancy, miscarried, lost a child to a stroke, or whose child showed signs of a bleeding disorder.

Enter one-time code:Show
Invalid code entered. Please try again.